Aquaculture for all

Yield10 and BioMar pen GM Camelina agreement

Atlantic Salmon Biotechnology Feed ingredients +6 more

Yield10 Bioscience and BioMar Group have signed an agreement to commercialise a genetically modified strain of Camelina that contains enriched levels of EPA and DHA, and can be used as a key ingredient in aquafeeds.

a field of Camelina plants.
The Camelina strain has been successfully cultivated at scale in the US

However, as the strain has been genetically modified it will need to pass through regulatory hurdles in key markets before it can be used commercially in aquafeeds

After a decade of research, according to BioMar, the technology is “now advancing toward market availability and has the potential to become another important, high-quality supplement to the scarce supply of marine long-chain fatty acids”.

This new Omega-3 Camelina product contains EPA and DHA levels comparable to many of the marine oil sources utilised today making it ideally designed for the needs of the aquaculture industry.

The strain has been developed by researchers at Rothamsted Research, while BioMar has been actively involved with the development since its inception in 2013, conducting many of the trials in which salmon were fed diets containing the Camelina oils.

“A partnership with BioMar has the potential to combine the strengths of both companies for the accelerated development of the Omega-3 Camelina product. We look forward to working closely with BioMar to develop a collaborative program to bring this new source of high-quality EPA and EPA+DHA omega-3 oils to the market to strive to meet the aquaculture industry's growth demand and sustainability goals,” said Dr Oliver Peoples, president and CEO of Yield10 Bioscience, in a press release.

Regulatory hurdles

Over the next year, Yield10 expects to scale-up the acreage of the GM Camelina to supply BioMar with oil for feed formulation and testing, while also working towards securing regulatory approval for commercial production of Omega-3 Camelina oil and meal in the targeted production geographies.

Yield10 and BioMar believe that the Omega-3 Camelina technology will play an important role in the future omega-3 market, enabling access to key nutrients from sustainable sources and paving the way for future growth within the aquaculture industry.

“We believe that the Yield10 Omega-3 Camelina technology represents a potentially excellent solution for producing crop omega-3 oils at commercial scale. Reliable and scalable sources of EPA and DHA are critical for aquafeeds to ensure the sustainable development of the aquaculture industry. We look forward to working together with the Yield10 team to make this product a commercial success,” stated Carlos Diaz, CEO of BioMar Group.

Create an account now to keep reading

It'll only take a second and we'll take you right back to what you were reading. The best part? It's free.

Already have an account? Sign in here